ArticleBMC women's health2026
Menstrual vulnerability to acute systemic stress: evidence from 884 women after COVID-19 infection.
Article in BMC women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMenstrual function is sensitive to inflammatory, endocrine, and psychosocial stressors that may transiently disrupt the hypothalamic-pituitary-ovarian axis. Although menstrual disturbances have been reported during the coronavirus disease 2019 (COVID-19) pandemic, large real-world data from Asian populations remain limited. We aimed to describe menstrual changes reported after COVID-19 infection and to identify potential vulnerability factors.
methodsWe conducted a retrospective cross-sectional survey using an electronic questionnaire among reproductive-aged women who had experienced at least one menstrual cycle following laboratory-confirmed or self-tested COVID-19 infection between January and March 2023. Participants reported menstrual characteristics before and after infection. Multivariable logistic regression analyses were performed adjusting for age, age of menarche, abnormal uterine bleeding (AUB)-related disease, pre-existing menstrual irregularity, vaccination status, and fever.
resultsAmong 884 participants, 662 (74.9%) reported at least one menstrual change after infection. Alterations most commonly involved cycle length (421/884, 47.6%), menstrual flow (369/884, 41.7%), and duration (261/884, 29.5%). Women with pre-existing irregular cycles were more likely to report post-infection changes than those with regular cycles. In adjusted analyses, pre-existing menstrual irregularity remained independently associated with reporting menstrual changes (adjusted OR 1.51, 95% CI 1.12-2.03).
conclusionsMenstrual disturbances were frequently reported following COVID-19 infection and showed substantial interindividual variability. These findings suggest that menstrual function may be vulnerable to acute systemic stress. Because the study was cross-sectional and based on self-reported outcomes, the findings should be interpreted as associative rather than causal and may have been influenced by recall or selection bias. Prospective longitudinal studies are warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.